GNH USA

Europe — EMA

Infectofos (Fosfomycin)

GNH USA supplies Infectofos (Fosfomycin), a antibacterial for complicated urinary tract infections and severe bacterial infections.

Fosfomycin

Request sourcing

1
Pack/s

What is Fosfomycin?

Fosfomycin, the active ingredient in Infectofos, is an antibacterial presented as an intravenous solution for intravenous use. It is employed to treat serious bacterial infections, including complicated urinary tract infections and severe soft‑tissue infections, and respiratory tract infections in hospitalized patients.

GNH USA supplies Infectofos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, ensuring quality compliance and reliable delivery across multiple markets through.

What is Fosfomycin used for?

Fosfomycin is used intravenously to treat infections caused by susceptible bacteria in several organ systems.

Complicated urinary tract infection: eradicates Gram‑negative pathogens causing upper urinary tract infection. Severe skin and soft‑tissue infection: provides bactericidal activity against resistant Staphylococcus aureus. Lower respiratory tract infection: treats hospital‑acquired pneumonia caused by susceptible organisms. Bone and joint infection: aids in the management of osteomyelitis when other agents are limited.

What are the side effects of Fosfomycin?

Fosfomycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Infusion site erythema or phlebitis - Elevated liver enzymes - Hypokalemia

Serious or Rare Side Effects: - Anaphylactic shock - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Clostridioides difficile‑associated colitis - Severe hepatic dysfunction - Acute renal failure - Hemolytic anemia

What precautions apply to Fosfomycin?

When prescribing intravenous fosfomycin, clinicians should consider several precautionary measures to ensure safe use.

- Renal function: adjust dose in patients with impaired renal clearance. - Electrolyte monitoring: watch for hypokalemia and correct as needed. - Hepatic status: monitor liver enzymes during prolonged therapy. - Concomitant antibiotics: avoid antagonistic combinations that may reduce efficacy. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Fosfomycin interact with?

Fosfomycin can interact with other medicines, altering its effectiveness or increasing toxicity.

Major Interactions (Avoid): - Aminoglycosides: antagonistic effect reducing antibacterial activity. - Warfarin: potentiates anticoagulant effect, may increase INR.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate electrolyte disturbances, especially hypokalemia. - Insulin or oral hypoglycemics: fosfomycin can enhance hypoglycemic effect. - Other nephrotoxic agents (e.g., vancomycin, NSAIDs): increase risk of renal impairment. - Antacids containing calcium or magnesium: may affect absorption if given orally.

Frequently asked questions

What is Infectofos used for?+
Infectofos is the brand name for an intravenous fosfomycin product. It is used in hospital settings to treat serious bacterial infections such as complicated urinary tract infections, severe skin and soft‑tissue infections, lower respiratory tract infections, and bone or joint infections caused by susceptible organisms.
How does fosfomycin work?+
Fosfomycin blocks the MurA enzyme, which is essential for the first step of bacterial cell‑wall synthesis. By preventing the formation of peptidoglycan, the drug weakens the bacterial wall, leading to rapid cell lysis. This mechanism is distinct from β‑lactam antibiotics and remains effective against many resistant strains.
What is the usual dose of Infectofos?+
The dosage of Infectofos is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and local guidelines. Healthcare professionals should follow the specific dosing recommendations provided in the product label or institutional protocol.
Is fosfomycin safe in pregnancy or breastfeeding?+
Safety data for intravenous fosfomycin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.
How do I order Infectofos from GNH USA?+
To order Infectofos, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and assistance with import documentation.
How does Infectofos compare with the main alternative drug or class?+
The primary alternative to intravenous fosfomycin is often a carbapenem or a broad‑spectrum β‑lactam. Fosfomycin offers a unique mechanism that can be effective against some carbapenem‑resistant organisms, and it may be used as a carbapenem‑sparing option. However, susceptibility testing is essential to guide therapy.
How should Infectofos be stored and handled?+
Infectofos should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Prior to administration, the solution should be inspected for particulate matter and used within the time frame recommended by the manufacturer.
How is Infectofos given or administered?+
Infectofos is administered by intravenous infusion under the supervision of qualified medical personnel. The infusion rate and duration are determined by the prescribing clinician, taking into account the patient’s renal function and the specific infection being treated.
What are the most serious risks to watch for?+
Serious adverse events associated with fosfomycin include anaphylactic reactions, Stevens‑Johnson syndrome or toxic epidermal necrolysis, severe hepatic dysfunction, acute renal failure, and Clostridioides difficile‑associated colitis. Prompt recognition and medical intervention are critical if any of these occur.
Who should not use Infectofos?+
Patients with known hypersensitivity to fosfomycin or any component of the formulation should avoid Infectofos. Caution is also advised for individuals with severe renal impairment, uncontrolled electrolyte disturbances, or those receiving drugs that may cause dangerous interactions, unless a risk‑benefit assessment justifies use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Fosfomycin
Route
Intravenous Use
Manufacturer
Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
Origin
EU

Related products

Afosfol

Afosfol

Fosfomycin

Goodwill Pharma Nyrt.
EU
Cystium

Cystium

Fosfomycin

Aristo Pharma Gmbh (Art 57)
EU
Danifos Adulti

Danifos Adulti

Fosfomycin

Pharmacare Srl
EU
Fomicyt

Fomicyt

Fosfomycin

Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
EU